Produktname:(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-amine
IUPAC Name:(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-amine
- CAS:2364560-36-9
- Molekulare Formel:C13H15N3O
- Reinheit:95%+
- Katalognummer:CM1046485
- Molekulargewicht:229.28
Packungseinheit |
Verfügbarer Vorrat |
Preis($) |
Menge |
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:2364560-36-9
- Molekulare Formel:C13H15N3O
- Schmelzpunkt:-
- SMILES-Code:C(C)C1=NC(C=2C=C3C(=CC2)[C@H](N)CC3)=NO1
- Dichte:
- Katalognummer:CM1046485
- Molekulargewicht:229.28
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Category Infos
- Oxadiazoles
- Oxadiazoles are a class of heterocyclic aromatic compounds with the molecular formula C2H2N2O, which have special biological activities and thermodynamic properties. Five-membered heterocyclic moieties composed of three or two heteroatoms are of great interest to researchers because these compounds show significant therapeutic potential. These heterocycles can serve as a building block for the development of novel molecular structures.
Column Infos
- Aficamten
- Evaluate Pharma recently issued an article listing "the most valuable potential drugs currently under development", and Aficamten is one of them. Aficamten is a novel cardiac myosin inhibitor for the treatment of hypertrophic cardiomyopathy, which achieves its therapeutic effect by reducing the hypercontractility of obstructive HCM and improving diastolic function.